Song-hyen Choi Selected Research

2- ethoxy- 3- (4- (3- methyl- 5- (4- (3- methylisoxazol- 5- yl)phenyl)thiophen- 2- ylmethoxy)phenyl)propionic acid

1/2011

PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Song-hyen Choi Research Topics

Disease

3	Insulin Resistance 01/2012 - 05/2009
1	Body Weight (Weight, Body) 01/2012
1	Glucose Intolerance 01/2012
1	Hyperglycemia 01/2011

Drug/Important Bio-Agent (IBA)

2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011 - 05/2009
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2012
1	4- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA 01/2012
1	2- ethoxy- 3- (4- (3- methyl- 5- (4- (3- methylisoxazol- 5- yl)phenyl)thiophen- 2- ylmethoxy)phenyl)propionic acidIBA 01/2011
1	PPAR gammaIBA 05/2009